BMY - Bristol-Myers Squibb Company

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue22,561,00020,776,00019,427,00016,560,000
Cost of Revenue6,490,0005,945,0004,948,0003,825,000
Gross Profit16,071,00014,831,00014,479,00012,735,000
Operating Expenses
Research Development5,131,0004,894,0004,477,0004,037,000
Selling General and Administrative4,522,0004,749,0004,907,0004,831,000
Non Recurring----
Others----
Total Operating Expenses16,143,00015,588,00014,332,00012,693,000
Operating Income or Loss6,418,0005,188,0005,095,0003,867,000
Income from Continuing Operations
Total Other Income/Expenses Net-450,000-57,000820,000-1,790,000
Earnings Before Interest and Taxes6,418,0005,188,0005,095,0003,867,000
Interest Expense-183,000-196,000-167,000-184,000
Income Before Tax5,968,0005,131,0005,915,0002,077,000
Income Tax Expense1,021,0004,156,0001,408,000446,000
Minority Interest96,000106,000170,000158,000
Net Income From Continuing Ops4,947,000975,0004,507,0001,631,000
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income4,920,0001,007,0004,457,0001,565,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares4,920,0001,007,0004,457,0001,565,000